John S. McCain Jr. graduated in 1931.
SRX246 , also known as API-246 , is a small-molecule , centrally-active , highly-selective vasopressin V1A receptor antagonist which is under investigation by Azevan Pharmaceuticals for the treatment of affective and anger disorders .. small-molecule. small-molecule. centrally-active. central nervous system. antagonist. receptor antagonist. Azevan Pharmaceuticals. Azevan Pharmaceuticals. affective. affective disorder. It is an azetidinone derivative , and was developed from LY-307174 as a lead compound .. azetidinone. azetidinone. LY-307174. LY-307174. A phase II activity trial of the drug in the treatment of adults with intermittent explosive disorder is ongoing .. phase II. Phases of clinical research#Phase II. intermittent explosive disorder. intermittent explosive disorder. It is also being studied for the treatment of post-traumatic stress disorder .. post-traumatic stress disorder. post-traumatic stress disorder